1. Home
  2. NTRA vs BAP Comparison

NTRA vs BAP Comparison

Compare NTRA & BAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$197.88

Market Cap

29.2B

Sector

Health Care

ML Signal

HOLD

Logo Credicorp Ltd.

BAP

Credicorp Ltd.

HOLD

Current Price

$329.01

Market Cap

26.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
BAP
Founded
2003
1889
Country
United States
Peru
Employees
N/A
N/A
Industry
Medical Specialities
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
29.2B
26.4B
IPO Year
2015
1997

Fundamental Metrics

Financial Performance
Metric
NTRA
BAP
Price
$197.88
$329.01
Analyst Decision
Strong Buy
Buy
Analyst Count
15
5
Target Price
$259.07
$309.60
AVG Volume (30 Days)
1.4M
345.6K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
3.46%
EPS Growth
0.65
N/A
EPS
N/A
N/A
Revenue
$210,939,000.00
N/A
Revenue This Year
$18.08
$23.26
Revenue Next Year
$19.65
$8.62
P/E Ratio
N/A
$12.91
Revenue Growth
N/A
N/A
52 Week Low
$131.81
$193.13
52 Week High
$256.36
$380.20

Technical Indicators

Market Signals
Indicator
NTRA
BAP
Relative Strength Index (RSI) 46.96 49.91
Support Level $187.27 $316.70
Resistance Level $204.34 $363.15
Average True Range (ATR) 10.36 9.13
MACD -1.12 0.45
Stochastic Oscillator 28.02 71.91

Price Performance

Historical Comparison
NTRA
BAP

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About BAP Credicorp Ltd.

Credicorp Ltd is a Peruvian financial services company. It operates in four business lines, including Universal Banking, Insurance and Pensions, Microfinance, and Investment Management & Advisory. Its subsidiaries include Banco de Credito del Peru, Prima AFP, and Credicorp Capital. Geographically, the company operates in Peru, Colombia, Bolivia, Chile, Panama, the USA, and Mexico; the majority of its revenue is generated from Peru.

Share on Social Networks: